Advancing continuous cardio-respiratory insight across care settings: Respiree
- By Philips
- March 26 2026
- 3 min read
As healthcare systems expand higher-acuity services into home environments and face persistent inpatient monitoring limitations, they require tools that extend clinical visibility beyond episodic patient monitoring checks of patient vital signs. This is especially the case when it comes to cardio‑respiratory function, one of the most sensitive indicators of patient decline. And as healthcare shifts toward hybrid models of in‑hospital, virtual and hospital‑at‑home care, the need for reliable, continuous cardio‑respiratory monitoring that spans care environments has never been more critical. Learn about all of our technology partnerships on our dedicated partnerships webpage.
At-a-glance:
- A Philips partnership with Respiree™ combines its wearable sensors and predictive AI with Philips monitoring ecosystem infrastructure.
- The integrated solution can be used for multiple care delivery models: in the hospital, during care transitions and in the community/home.
- Real-world deployments show how this integrated monitoring ecosystem can enable health systems to scale higher-acuity services within and beyond facility walls.
- This partnership reinforces Philips commitment to delivering safe, connected, insight‑driven care across in‑hospital, virtual and home‑based environments.
That’s why Philips has partnered with Respiree, whose AI‑enabled cardio‑respiratory wearables and predictive AI analytics support Philips strategy to advancing monitoring capabilities collaboratively through inpatient monitoring optimization and the expansion of Hospital-at-Home programs.
Specifically, the partnership brings together Philips enterprise monitoring infrastructure with Respiree’s wearable sensors, which monitor everything from respiration rate and tidal volume to oxygen saturation, heart rate variability and patient activity. The streams of patient data from the sensors run through 1BioTMAI algorithms to deliver physiologic insight that extends beyond traditional vital signs monitoring. For example, Respiree provides longitudinal biomarker trending and early deterioration detection that enables earlier intervention, supports virtual care delivery and addresses critical monitoring gaps healthcare systems face today.
Key reasons why Philips joined forces with Respiree include its:
- Continuous AI‑driven respiratory intelligence (1BioTMAI) that supports earlier recognition of deterioration and more proactive clinical intervention
- CE‑approved and FDA‑cleared measurements that deliver high‑quality lung‑cardio biomarkers for both in‑hospital and at‑home monitoring
- Interoperability roadmap with Philips enterprise platforms, enabling streamlined workflows and unified patient insight across care settings
- Real-world deployments that demonstrate readiness in out‑of‑hospital monitoring models
One solution for multiple care delivery models
The Philips-Respiree partnership facilitates a model of continuous and scalable cardio-respiratory surveillance that can be applied across acute care, transitional care and community or home care.
In the hospital
Patients can be fitted with the wearable during a hospital stay to provide continuous respiratory intelligence that supplements bedside monitoring. Data flows through Philips enterprise connectivity platforms for streamlined, integrated patient insight and alarming.
Transitional care
A patient may get the wearable before discharge to maintain physiologic visibility as they transition home. Hospital-based clinicians can remotely and continuously monitor their vital signs, such as breathing rate, oxygen levels, heart rate and blood pressure, in near-real time using the Philips monitoring infrastructure.
Community and home care
Virtual, acute-care level oversight by hospital-based clinicians of patients in home or community settings supports many health systems’ expanding Hospital-at-Home strategies. This model can enhance the patient experience, improve outcomes and reduce overall system costs, while empowering clinicians in both urban and rural environments. For patients, it offers the opportunity to recover, or to be proactively monitored, in the comfort and familiarity of home. For clinicians, it provides critical visibility into continuous cardio-respiratory data outside the hospital, enabling earlier detection of deterioration and proactive intervention.
Major deployments demonstrate real‑world readiness
Philips rollout of the Respiree solution in North American with Kindred LTAC Hospital, as well as throughout Australia’s Southern New South Wales Home program suggests commercial viability and clinical value. Through these successful deployments, healthy systems have demonstrated how integrated monitoring ecosystems can help healthcare systems to safely scale higher-acuity services within and beyond the hospital.
Our strategy is centered on building an open ecosystem that integrates a broad network of partner solutions. By doing so, we accelerate innovation and give healthcare providers greater choice in how they deliver care. This approach helps enable clinical workflows, brings new technologies to the point of care faster.
Sangdo Kim
NextGen Acute & Transitional Monitoring Category Leader
Expanding Philips ability to deliver clinical insights
The Philips monitoring ecosystem has long enabled clinicians to make confident decisions through access to reliable, high‑quality patient data. Our partnership with Respiree strengthens this foundation in several ways:
- While traditional patient monitoring often identifies issues only after deterioration occurs, Respiree helps support early detection. This is especially important when patients move between acute, post‑acute and home‑based settings – a time when early warning, remote monitoring and end-to-end escalation routes are essential.
- The collaboration supports pathways for interoperability with Philips platforms, such as our centralized interoperability platform, IntelliBridge Enterprise, our patient information center (PIC iX) and Capsule Medical Device Integration Platform.
- The partnership complements our long‑term strategy to build an open, platform‑based patient monitoring ecosystem that anchored by actionable insights, continuous sensing and interoperable technology partnerships.
Copy this URLto share this story with your professional network
Disclaimer
Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. Results in other cases may vary.